Nubeqa 300 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FGPKD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,284
Award facts
- Contract value 100% obligated
- $15,283.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $15,283.96 to AmerisourceBergen Drug Corp for the supply of Nubeqa 300 mg tablets (120 count). The contract, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, establishing a comprehensive global pharmaceutical support vehicle.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical supplies to military and veteran healthcare systems. Nubeqa (apalutamide) is a prescription medication used in the treatment of prostate cancer, representing the specialized pharmaceutical products that fall within the company's extensive therapeutic domain coverage under its DLA prime contract. The firm's federal procurement history demonstrates consistent capability to fulfill competitive awards for medical supply needs across multiple therapeutic areas, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet diverse military healthcare requirements globally.
Quick answers
Who was awarded contract SPE2DB25FGPKD?
SPE2DB25FGPKD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FGPKD worth?
The government has obligated $15,284 on SPE2DB25FGPKD.
Is contract SPE2DB25FGPKD an order under another contract?
Yes. SPE2DB25FGPKD is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPKD competed?
The extent of competition for SPE2DB25FGPKD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award